April 25, 2013 /3BL Media/ - Free products, regular testing, easy access to doctors – and the opportunity to survive for more than a year and live a life with type 1 diabetes - as close as possible to a normal life. The notable benefits from Novo Nordisk’s Changing Diabetes in Children® programme have now reached 10,000 children, one year ahead of time.
Type 1 diabetes in children causes high mortality in developing countries. A child diagnosed with diabetes in sub-Saharan Africa, for example, has a life expectancy of less than one year1. To do something about the lack of treatment and care for these children, Novo Nordisk started the Changing Diabetes® in Children (CDiC) programme in 2009.
Now, Novo Nordisk has reached a milestone together with the local partners: 10,000 children with type 1 diabetes in developing countries are enrolled and receive lifesaving treatment.
Reports from the nine participating countries show that 77 clinics have been established and tha